Most and least shorted mid- to mega-cap healthcare stocks at the end of May
Source: SeekingAlpha
2026-06-03 09:35:45 ET
- BeOne Medicines AG (ONC) Discusses Solid Tumor Portfolio Progress and R&D Pipeline Strategy at ASCO Transcript
- Bausch + Lomb Corporation (BLCO) Discusses Project Halo and Myopia Control Developments in Vision Care Transcript
- Bausch + Lomb Corporation (BLCO) Discusses Project Halo and Myopia Control Developments in Vision Care - Slideshow
- J&J lupus drug meets primary endpoint in Phase 2 study
- Draft FDA guidance could be a boon for gene therapy developers
Read the full article on Seeking Alpha
For further details see:
Most and least shorted mid- to mega-cap healthcare stocks at the end of May
Bausch + Lomb Corporation
NASDAQ: BLCO
BLCO Trading
0.43% G/L:
$15.37 Last:
213,909 Volume:
$15.30 Open:
BLCO Latest News
June 01, 2026 06:59:00 am
Bausch + Lomb Launches Blink® Triple Care Preservative Free Lubricant Eye Drops in the United States
May 21, 2026 07:15:00 am
Bausch + Lomb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
May 19, 2026 07:00:00 am
Bausch + Lomb Launches PreserVision AREDS3(TM) Eye Vitamins in the United States
BLCO Stock Data
$6,074,354,796
39,385,904
0.1%
19
N/A
Medical Equipment & Supplies
Healthcare
CA
Vaughan
